Shows
Cleveland Clinic Cancer AdvancesSetting the Standard: Cleveland Clinic Children’s First-in-Nation Pediatric Cancer AccreditationMatteo Trucco, MD, Director of the Children’s Cancer Innovative Therapy Program, joins the Cancer Advances Podcast to discuss the Cleveland Clinic Children's recent recognition as the first center in the nation to receive pediatric cancer subcommittee accreditation from the Commission on Cancer. Learn how this milestone is not only advancing pediatric cancer care at Cleveland Clinic but also shaping national benchmarks for multidisciplinary pediatric oncology programs.2025-05-2915 min
Cleveland Clinic Cancer AdvancesVirtual Anemia ClinicMailey Wilks, CNP, APP manager at the Taussig Cancer Center, and Heather Koniarczyk, CNP, Director of Advanced Practice, join the Cancer Advances Podcast to discuss the implementation and success of a Virtual Anemia Clinic. The clinic was developed to address the increased demand for anemia consult requests and aim to reduce average wait times. Listen as they explain how the virtual platform allows for convenient and timely consultations, a 70% retention rate, and the plans for future expansions.2024-02-0121 min
Cleveland Clinic Cancer AdvancesA Decade of VeloSanoMr. Stewart Kohl, co-CEO of the Riverside Company, a member of the board of directors at Cleveland Clinic, and founder of VeloSano joins the Cancer Advances podcast to celebrate 10 years of Cleveland Clinic's cancer research fundraising initiative, VeloSano. Listen as Mr. Kohl talks about the journey of VeloSano's 10-year impact on advancing cancer research.2023-08-1717 min
Cleveland Clinic Cancer AdvancesUnlocking Treatment Strategies for Anaplastic Thyroid CancerJoseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute, and Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute, specializing in head and neck cancers, join the Cancer Advances podcast to discuss their study that provides insights to treatment strategies and tumor characteristics of anaplastic thyroid cancer. Listen as Dr. Scharpf and Dr. Yilmaz discuss patients with BRAF mutations and Cleveland Clinic's collaborative approach for thyroid cancer care.2023-06-1521 min
Cleveland Clinic Cancer AdvancesMonoclonal Gammopathy of Undetermined Significance (MGUS)Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.2023-05-1821 min
Cleveland Clinic Cancer AdvancesNovel Therapeutics ClinicAlex A. Adjei, MD, PhD, Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to discuss the new Novel Therapeutics Clinic. Listen as Dr. Adjei shares the importance of novel cancer therapetuics, how the clinic is structured, and his hopes of having multiple treatment options for every cancer.2023-04-2025 min
Cleveland Clinic Cancer AdvancesRetinoblastomaArun D. Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, and Stacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's join the Cancer Advances podcast to discuss retinoblastoma. Listen as they discuss this unique children's eye cancer, the treatment options available, and the genetic counseling we have at Cleveland Clinic.2023-04-1321 min
Cleveland Clinic Cancer AdvancesNew ASCO Guidelines for Recurrent and Metastatic Head and Neck CancersEmrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute specializing in head and neck cancers, joins the Cancer Advances podcast to discuss new ASCO guidelines for recurrent and metastatic head and neck cancers. Listen as Dr. Yilmaz explains how the guidelines focus on biomarkers, tumor mutation burdens, and how they will impact patient care.2023-04-0618 min
Cleveland Clinic Cancer AdvancesInsights into the MOMENTUM TrialAaron Gerds, MD, MS, a hematologist in Cleveland Clinic Cancer Center’s Leukemia and Myeloid Disorders Program and Deputy Director for Clinical Research at the Taussig Cancer Institute joins the Cancer Advances podcast to talk about the MOMENTUM trial that was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Gerds discusses myelofibrosis, the differences between the trial results from 24 to 48 weeks, and the exciting new approaches that are coming to the field.2023-03-3020 min
Cleveland Clinic Cancer AdvancesMental Health of Children and Teens with CancerThe Cancer Advances podcast is joined by Kate Eshleman, PsyD, a pediatric psychologist in the Center for Pediatric Behavioral Health at Cleveland Clinic Children's to talk about the mental health of children and teenagers with cancer. Listen as Dr. Eshleman discusses the Cleveland Clinic Children's survivorship program, what medical professionals should watch out for, and how to assist patient families.2023-03-1617 min
Cleveland Clinic Cancer AdvancesManaging the Differences between Invasive Lobular Breast Cancer and Invasive Ductal Breast CancerBreast Medical Oncologist at Cleveland Clinic Taussig Cancer Institute, Megan Kruse, MD, joins the Cancer Advances podcast to discuss the differences in the clinical management of invasive lobular breast cancer (ILC) and invasive ductal breast cancer (IDC). Listen as Dr. Kruse discusses the challenges of diagnosing, re-evaluating treatment options, and using genomic data to see different trends for lobular and ductal breast cancer.2023-02-2322 min
Cleveland Clinic Cancer AdvancesPredicting Survival using Genomic Adjusted Radiation DoseJacob Scott, MD, DPhil, radiation oncologist, associate professor, and staff physician-scientist at Cleveland Clinic, joins the Cancer Advances podcast to talk about the research he presented at the American Society of Radiation Oncology (ASTRO) 2022 Annual Meeting. Listen as Dr. Scott discusses preliminary results from a recent Cleveland Clinic study about using GARD to predict overall survival in patients with HPV positive oropharyngeal squamous cell carcinoma treated with radiotherapy.2023-02-0225 min
Cleveland Clinic Cancer AdvancesAdvances in Pediatric Neuroblastoma CareStacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's, joins the Cancer Advances podcast to talk about the advances in neuroblastoma care for pediatric patients. Listen as Dr. Zahler talks about current treatment options, creating a metaiodobenzylguanidine (MIBG) therapy center at Cleveland Clinic, and studying difluoromethylornithine (DFMO) against cancer cells.2023-01-0518 min
Cleveland Clinic Cancer AdvancesPsycho-Oncology SupportThe emotional, psychological, and mental challenges of living with cancer are significant. In this Cancer Advances Podcast, Kaleena Chilcote, MD, Director of Psycho-Oncology at Taussig Cancer Institute talks about mental healthcare in patients who have cancer. Listen as Dr. Chilcote talks about cancer patients' mental health struggles from the beginning of their journey through survivorship and highlights how oncologists can collaborate with psychiatrists to help cancer patients with their quality of life.2022-12-1520 min
Cleveland Clinic Cancer AdvancesNew Leader’s Vision for Cleveland Clinic Cancer CenterAlex A. Adjei, MD, PhD, the new Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to share his vision for Cleveland Clinic Cancer Center. Listen as Dr. Adjei shares his background, goals, and his vision to integrate clinical trials as first line therapy in patient care.2022-12-0825 min
Cleveland Clinic Cancer AdvancesFDA Approved: Lutetium-PSMA for Metastatic Prostate CancerChristopher Wee, MD, a medical oncologist from the Genitourinary Medical Oncology Program at Taussig Cancer Institute joins the Cancer Advances podcast to talk about therapies for metastatic prostate cancer. Listen as Dr. Wee discusses Lutetium-PSMA and the clinical trials that showed patients had better response rates and fewer toxicities when they got lutetium on top of their care.2022-11-1018 min
Cleveland Clinic Cancer AdvancesInsights into the MAIN-CAV Trial for Patients with Urothelial CancerShilpa Gupta, MD, director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the genitourinary oncology program at Cleveland Clinic Cancer Center joins the Cancer Advances podcast to discuss her research that was presented at the American Society of Clinical Oncology (ASCO) 2022 annual meeting. Listen as Dr. Gupta gives us insights into the MAIN-CAV trial and platinum-ineligibility in metastatic urothelial cancer.2022-10-2018 min
Cleveland Clinic Cancer AdvancesNomogramsMichael Kattan, PhD, Chair of the Department of Quantitative Health Sciences at Cleveland Clinic, and Rahul Tendulkar, MD, radiation oncologist at Cleveland Clinic Cancer Center join the Cancer Advances podcast to discuss nomograms, a calculation tool designed to allow clinicians to evaluate the collective risk of multiple factors at once. Listen as they discuss the creation of nomograms and how they can be helpful to evaluate treatment options for cancer patients.2022-09-2223 min
Cleveland Clinic Cancer AdvancesVeloSano: Cancer Research FundraisingNicole Peters, Executive Director of VeloSano in the Cleveland Clinic Philanthropy Institute, joins the Cancer Advances podcast to talk about VeloSano, a year-round fundraising initiative that supports lifesaving cancer research at Cleveland Clinic. Listen as Nicole discusses how VeloSano was started, our flagship Bike to Cure weekend, and highlights of how 100% of the funds go toward advancing cancer research.2022-08-1819 min
Cleveland Clinic Cancer AdvancesAggressive Lymphoma Early Alert ProcessCleveland Clinic hematology oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss the early alert process for aggressive lymphoma. Listen as Dr. Winter covers the importance of time to treat for this disease and what Cleveland Clinic is doing to help see patients sooner.2022-08-1118 min
Cleveland Clinic Cancer AdvancesKRYSTAL-1 Lung Cancer TrialDirector of the Lung Cancer Medical Oncology Program at Cleveland Clinic Taussig Cancer Institute, Nathan A. Pennell, MD, PhD joins the Cancer Advances podcast to discuss the KRYSTAL-1 trial, a new treatment option for patients with advanced non-small-cell lung cancer with KRASG12C mutation. Listen as Dr. Pennell explains the trial and findings that were presented at the American Society of Clinical Oncology (ASCO) 2022 annual meeting.2022-08-0424 min
Cleveland Clinic Cancer AdvancesBenefits of Virtual Second OpinionsPeter Rasmussen, MD, cerebral vascular surgeon and Chief Clinical Officer of Virtual Second Opinions by Cleveland Clinic, joins the Cancer Advances podcast to discuss the benefits of Virtual Second Opinions. Listen as Dr. Rasmussen talks about this service at Cleveland Clinic and our goal to give patients the best opinion on what they can do now and in the future.2022-06-0221 min
Cleveland Clinic Cancer AdvancesLess-Intensive Therapies for Acute Myeloid Leukemia Tied to Higher Mortality RisksAaron Gerds, MD, MS, hematologist in Cleveland Clinic Cancer Center’s Leukemia & Myeloid Disorders Program joins the Cancer Advances podcast to talk about acute myeloid leukemia. Listen as Dr. Gerds discusses less intensive therapies for acute myeloid leukemia and their impact on mortality.2022-04-1423 min
Cleveland Clinic Cancer AdvancesVaccine Research for Head and Neck CancersDirector of Head and Neck Research and surgical oncologist at Cleveland Clinic, Natalie Silver, MD, MS, joins the Cancer Advances podcast to talk about head and neck cancers and the treatment barriers we are trying to overcome. Listen as Dr. Silver explains how she is trying to bridge the gap between the clinical and translational research with her work on vaccines.2022-04-0724 min
Cleveland Clinic Cancer AdvancesModified Drug Regimen May Reduce Risks in Allogeneic Hematopoietic Cell Transplant PatientsBetty Hamilton, MD, Interim Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hamilton discusses graft-versus-host disease and the study that evaluates a new regimen.2022-03-3119 min
Cleveland Clinic Cancer AdvancesGene Therapy in Sickle Cell DiseaseRabi Hanna, MD, Chair of the Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's joins the Cancer Advances podcast to discuss the use of gene therapy in sickle cell disease. Listen as Dr. Hanna describes how the last several years have brought significant advancements in the field, expanding our understanding and treatment of sickle cell disease, including the possibility of curative gene therapy.2022-03-2420 min
Cleveland Clinic Cancer AdvancesFunctional Drug Screening and Genomic Profiling in Advanced SarcomaProgram Director of Cleveland Clinic Florida's Sarcoma Program, Jorge Manrique-Succar, MD, joins the Cancer Advances podcast to discuss a feasibility study for drug sensitivity testing and genetic profiling in adults with advanced sarcomas. Listen as Dr. Manrique-Succar highlights how the results from the study will lay grounds for future testing and potentially guide future treatment options.2022-03-1715 min
Cleveland Clinic Cancer AdvancesLysosomal Storage Disease ProgramRabi Hanna, MD, Chair of the Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's and Angelika Erwin, MD, PhD, Medical Geneticist at the Center for Personalized Genetic Healthcare at the Cleveland Clinic join the Cancer Advances podcast to discuss the lysosomal storage disease program (LSD). Listen as Dr. Hanna and Dr. Erwin discuss how the interdisciplinary team for children and adults with LSDs is dedicated to improving diagnosis, management and treatment of these disorders.2022-03-1024 min
Cleveland Clinic Cancer AdvancesTreating Retroperitoneal SarcomaNathan Mesko, MD, Center Director, Orthopaedic Oncology, and Co-Director of Sarcoma Care at Cleveland Clinic and Daniel Joyce, MBBCh, surgical oncologist, join the Cancer Advances podcast to discuss the treatment of retroperitoneal sarcomas. Listen as Dr. Mesko and Dr. Joyce highlight the value of having a multidisciplinary team to ensure the best outcomes for patients with retroperitoneal sarcoma.2022-03-0324 min